Dennis Bittner, PhD

Telepsychiatry shown to be viable alternative in rural areas with limited access.

An Evaluation of a Project ECHO Mental Health Pilot

Suicide is now the 10th leading cause of death in the US, with over 40,000 people dying by suicide each year, at a cost of about $44B annually.

One expert discussed the utility of measurement-based care in helping guide clinical decision-making.

The APA lecture focused on a model with detail to game theory.

The study presented at APA was in response to emergency department overcrowding.

Tele-psychiatry is a good way to provide psychotherapy to patients with HIV/AIDS.

Study examined the impact of incidents of adversity experienced in childhood.

Autism inked to maternal lifestyle, especially dietary factors impacting glucose.

Delirium-catatonia has been successfully treated with NMDA antagonists.

Mortality from serious mental illness is associated with metabolic disorder.

Study finds associations between psychiatric length of stay and readmission.

AF is linked with increased risks of stroke, dementia, and heart failure.

A physician shares the history of Zika, best practices to limit transmission.

Panagiota Caralis, MD, lectures on strategies for avoiding medical errors.

After decades of decline, heart disease mortality is on the rise again.

What are existing strategies to prevent heart disease?

What topics are important for PCPs to understand to treat their CVD patients?

Primary care physicians (PCPs) and ophthalmologists (including retina specialists) can effectively collaborate to minimize the occurrence of blindness in their diabetic patients.

PCPs must be aware of all potential therapies to help reduce the burden of HF.

How a combination of the conditions can take 15 years off a patient's life expectancy.

Phase III trial shows that transplanted purified human pancreatic islets safely restored sustained near-normoglycemia and provided protection from severe hypoglycemia in patients with long-standing type 1 diabetes and iatrogenic hypoglycemia.

Researchers find that the ratio of total cholesterol to HDL is a significant predictor for CVD in type 1 diabetes patients who are not using lipid-lowering drugs, and that the ratio of total cholesterol to HDL is a more reliable marker for risk when considering primary prevention.

Researchers have identified a previously unrecognized mechanism for SGLT2 inhibitors in the regulation of glucagon and gluconeogenic gene expression.

Patients with type 1 diabetes who had more depressive symptoms measured at baseline and over time appear to be at an increased risk of mortality, even after allowing for likely mediators.

Patients with type 2 diabetes and inadequate glycemic control treated with dapagliflozin plus metformin and sulfonylurea experienced sustained improvements in HbA1c, fasting plasma glucose, weight loss, and systolic blood pressure over 52 weeks.

Patients between the ages of 55 and 80 with type 2 diabetes treated with canagliflozin for more than 100 weeks experienced significant reductions in HbA1C, fasting plasma glucose, bodyweight, and systolic blood pressure.

Study results show long-term treatment with empagliflozin was well tolerated and associated with reductions in HbA1c, bodyweight, and systolic blood pressure compared with placebo and sitagliptin.

Study results presented at ADA 2014 show combination treatment with metformin plus linagliptin delivered consistent HbA1c reductions across different subgroups of patients newly diagnosed with type 2 diabetes, with decreased risk of hypoglycemia.

Study results show that an alternative to currently-marketed injectable agents retains the efficacy of GLP-1 mimetics, while reducing gastrointestinal adverse events and providing the convenience of oral dosing.